Tarsus Pharmaceuticals, Inc. · 2 days ago
Manager II, Quality Assurance (Commercial)
Irvine, California, United States
Full-time
Hybrid
Mid, Senior Level
$120K/yr - $168K/yr
8+ years expTarsus Pharmaceuticals, Inc. is a company focused on quality assurance in the pharmaceutical industry, and they are seeking a Manager II, Quality Assurance. This role involves reviewing and processing manufacturing deviations, laboratory OOS, and change controls, as well as authoring product reviews and analyzing data.
BiopharmaBiotechnologyLife Science
Responsibilities
Review/Approve Vendor Change Controls
Review/Approve vendor documents including Master Batch Records/Master Packaging Records
Review Specifications
Review/Approve Deviations/OOS
Analyze and trend data
Author Annual Product Reviews
Author/Revise relevant Quality Assurance Procedures
Review new proposed master manufacturing records and manufacturing-related process validation protocols
Review/Approve Test Record Review Form and Certificate of Analysis
Review/Approve executed manufacturing batch records and packaging batch records
Review/Approve/Complete Batch Record Review Form (Batch Disposition)
Complete Final Product Disposition Form and Certificate of Compliance
Participate in internal Operations
Participate in Meetings/ discussions with Tarsus’ manufacturing partners and testing laboratories
Qualification
Required
8+ years' experience in the Pharmaceutical Industry
5+ years experience in Pharmaceutical Quality Assurance
Strong attention to detail
Proficient technical skills across multiple platforms
Strong knowledge of Microsoft Office Systems
Preferred
Bachelor's Degree
ASQ Certification
Benefits
Health, dental and vision insurance benefits
Generous paid time off, including vacation, holidays, and personal days
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Jeffrey Farrow
Chief Financial Officer and Chief Strategy Officer
Bobak Azamian
Chairman
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase